(Updates with Pfizer’s response to CPSC release)
Pfizer is developing new packaging for Nurtec ODT 75mg 8-Unit Dose blister packs after it was determined that the current packs did not meet child-resistant packaging safety requirements, according to a statement from the company.
- Consumer Product Safety Commission (CPSC)
estimates 4.2m units affected- A spokesperson for Pfizer said 4.2m represents the total number of units distributed since Biohaven first produced the packaging in late 2021, prior to Pfizer’s
acquisition of the company, which was completed in October 2022 - Pfizer estimates around 300,000 units currently in circulation
- Pfizer brought the issue to the ...
- A spokesperson for Pfizer said 4.2m represents the total number of units distributed since Biohaven first produced the packaging in late 2021, prior to Pfizer’s